Shenzhen Haibin Pharmaceutical is an API manufacturer based in China. It holds 6 active US drug master files and 2 valid CEPs across a filed portfolio of 4 molecules. Its filings concentrate with NCELS (KZ), ARCSA (EC) and INVIMA (CO). Its GMP standing is certified by MFDS (Korea) and EMA.
| Site | FDA FEI |
|---|---|
| Shenzhen City, China | Not on file |
| Shenzhen, China | Not on file |
| China, China | 3041598181 |
| Molecule | Regulators | Docs |
|---|---|---|
| Meropenem | US FDA | 4 |
| Meropenem Trihydrate | EDQM | 2 |
| Efinaconazole | US FDA | 1 |
| Oseltamivir | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| NCELS (KZ) | 4 | None |
| ARCSA (EC) | 2 | None |
| INVIMA (CO) | 1 | None |
| MFDS (Korea) | None | 2 |
| EMA | None | 1 |
Choose your molecules and target markets. Shenzhen Haibin Pharmaceutical comes back tiered against every other supplier able to file there.
Start for free